Avai Bio AVAI
OTC AVAI
$0.11 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Avai Bio (AVAI) Revenue (2019 - 2020)

Avai Bio's (AVAI) quarterly Revenue came in at $154782.0 in Q4 2020, down 56.35% quarter-over-quarter from $354603.0 in Q3 2020.

Analysis

Avai Bio (AVAI) Revenue (2019 - 2020) Analysis & Trends

Avai Bio has disclosed Revenue across 2 years of filings, most recently posting $154782.0 for Q4 2020.

  • In Q4 2020, Revenue changed N/A year-over-year to $154782.0; the TTM figure through Dec 2020 stood at $1.5 million (up 25234.13% YoY), while the FY2023 annual figure was $276324.0, changed N/A from the prior year.
  • Revenue came in at $154782.0 for Q4 2020 at Avai Bio, down from $354603.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $711450.0 in Q1 2020 to a low of $6000.0 in Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Baidu 4.12 Bn -18.28 Bn 1.76 Mn 4.62 Bn
2 Life360 3.45 Bn 3.18 Bn 126.90 Mn 158.96 Mn
3 Soundhound Ai 2.76 Bn 2.56 Bn 27.93 Mn 61.90 Mn
4 C3.ai 1.46 Bn 885.89 Mn 11.32 Mn 51.60 Mn
5 Spectral Capital 455.65 Mn 450.34 Mn 3.28 Mn 318.28 Mn
6 Spire Global 433.12 Mn 341.45 Mn 6.16 Mn 18.05 Mn
7 Global AI 147.15 Mn 147.11 Mn 82,446.00 115,724.00
8 Veritone 81.80 Mn 69.38 Mn 15.46 Mn 24.26 Mn
9 Agassi Sports Entertainment 81.18 Mn 81.11 Mn - -
10 Avai Bio 18.47 Mn 18.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 154,782.00
Sep 30, 2020 354,603.00
Jun 30, 2020 299,213.00
Mar 31, 2020 711,450.00
Jun 30, 2019 6,000.00